Polycystic Kidney Disease (PKD) Study
FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Qualified volunteers will receive at no cost:
- Study medication
- Study-related care from a local doctor
- Reimbursement for your time and travel upto $1,960.00
If you are interested you should:
- Be 18 to 70 years of age
- Have been diagnosed with ADPKD
For more information, please visit or call our office at 614-487-2560 or email us at info@remdavis.com